Skip to main content
Clinical Trials/ACTRN12616000789460
ACTRN12616000789460CompletedPhase 4

Paclitaxel-eluting balloon Versus plain angioplasty balloon for dysfunctional dialysis access: a prospective double-blinded randomized controlled trial

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong0 sites40 target enrollmentStarted: June 16, 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • Native arteriovenous fistula or prosthetic arteriovenous graft in the upper limb
  • Vascular access actively used for hemodialysis
  • At least 1 previous successful session of hemodialysis via access
  • Clinical signs of failing access due to presence of significant anatomic stenosis
  • Detection of elevated venous pressure during dialysis and/or decreased blood flow
  • Angiographically/sonographically proven venous outflow stenosis >50%

Exclusion Criteria

  • Patient unable to provide informed consent
  • Patient unable to abide with study follow-up protocol
  • Patient participating in other relevant or conflicting studies
  • Vascular access circuit placed in the lower extremities
  • Bare metal stent or stent graft placed previously
  • Hemodynamically significant stenosis of the central venous system
  • Metastatic malignancy or other terminal medical condition
  • Limited life expectancy (<6 months)
  • Blood coagulation disorders
  • Sepsis or active infection
  • Recent arm thrombophlebitis (<6 months)
  • Allergy or other known contraindication to iodinated contrast media, heparin, or paclitaxel

Investigators

Sponsor
Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong

Similar Trials